UniProt P10599
P10599
P10599 (UniProt P10599): 70 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P10599
- Experimental structures
- 70
- Predicted models
- 0
Structures
70 records of P10599 in the MolNFT archive: 70 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1AIU | Human thioredoxin (D60N mutant, reduced form) | x-ray diffraction | A | — | — |
| 1AIU | Human thioredoxin (D60N mutant, reduced form) | x-ray diffraction | A | — | — |
| 1AUC | Human thioredoxin (oxidized with diamide) | x-ray diffraction | A | — | — |
| 1AUC | Human thioredoxin (oxidized with diamide) | x-ray diffraction | A | — | — |
| 1CQG | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1CQG | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1CQH | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1CQH | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1ERT | Human thioredoxin (reduced form) | x-ray diffraction | A | — | — |
| 1ERT | Human thioredoxin (reduced form) | x-ray diffraction | A | — | — |
| 1ERU | Human thioredoxin (oxidized form) | x-ray diffraction | A | — | — |
| 1ERU | Human thioredoxin (oxidized form) | x-ray diffraction | A | — | — |
| 1ERV | Human thioredoxin mutant with cys 73 replaced by ser (reduced form) | x-ray diffraction | A | — | — |
| 1ERV | Human thioredoxin mutant with cys 73 replaced by ser (reduced form) | x-ray diffraction | A | — | — |
| 1ERW | Human thioredoxin double mutant with cys 32 replaced by ser and cys 35 replaced by ser | x-ray diffraction | A | — | — |
| 1ERW | Human thioredoxin double mutant with cys 32 replaced by ser and cys 35 replaced by ser | x-ray diffraction | A | — | — |
| 1M7T | Solution Structure and Dynamics of the Human-Escherichia coli Thioredoxin Chimera: Insights into… | solution nmr | A | — | — |
| 1M7T | Solution structure and dynamics of the human-escherichia COLI thioredoxin chimera: insights into… | solution nmr | A | — | — |
| 1MDI | High resolution solution NMR structure of mixed disulfide intermediate between mutant human… | solution nmr | A | — | — |
| 1MDI | High resolution solution NMR structure of mixed disulfide intermediate between mutant human… | solution nmr | A | — | — |
| 1MDJ | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1MDJ | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1MDK | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1MDK | High resolution solution NMR structure of mixed disulfide intermediate between human thioredoxin… | solution nmr | A | — | — |
| 1TRS | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRS | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRU | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRU | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRV | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRV | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRW | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 1TRW | The high-resolution three-dimensional solution structures of the oxidized and reduced states of… | solution nmr | A | — | — |
| 2IFQ | Crystal structure of S-nitroso thioredoxin | x-ray diffraction | A, B, C | — | — |
| 2IFQ | Crystal structure of S-nitroso thioredoxin | x-ray diffraction | A, B, C | — | — |
| 2IIY | Crystal structure of S-nitroso thioredoxin | x-ray diffraction | A | — | — |
| 2IIY | Crystal structure of S-nitroso thioredoxin | x-ray diffraction | A | — | — |
| 3E3E | Human Thioredoxin Double Mutant C35S,C73R | x-ray diffraction | A, B | — | — |
| 3E3E | Human thioredoxin double mutant C35S,C73R | x-ray diffraction | A, B | — | — |
| 3KD0 | Human thioredoxin C35S,C62S,C69S,C73S mutant showing cadmium chloride bound to the active site | x-ray diffraction | A | — | — |
| 3KD0 | Human thioredoxin C35S,C62S,C69S,C73S mutant showing cadmium chloride bound to the active site | x-ray diffraction | A | — | — |
| 3M9J | Crystal structure of human thioredoxin C69/73S double mutant, reduced form | x-ray diffraction | A, B | — | — |
| 3M9J | Crystal structure of human thioredoxin C69/73S double mutant, reduced form | x-ray diffraction | A, B | — | — |
| 3M9K | Crystal structure of human thioredoxin C69/73S double-mutant, oxidized form | x-ray diffraction | A, B | — | — |
| 3M9K | Crystal structure of human thioredoxin C69/73S double-mutant, oxidized form | x-ray diffraction | A, B | — | — |
| 3QFA | Crystal structure of the human thioredoxin reductase-thioredoxin complex | x-ray diffraction | C, D | — | — |
| 3QFA | Crystal structure of the human thioredoxin reductase-thioredoxin complex | x-ray diffraction | C, D | — | — |
| 3QFB | Crystal structure of the human thioredoxin reductase-thioredoxin complex | x-ray diffraction | C, D | — | — |
| 3QFB | Crystal structure of the human thioredoxin reductase-thioredoxin complex | x-ray diffraction | C, D | — | — |
| 3TRX | High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution | solution nmr | A | — | — |
| 3TRX | High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution | solution nmr | A | — | — |
| 4LL1 | The structure of the TRX and TXNIP complex | x-ray diffraction | B, D | — | — |
| 4LL1 | The structure of the trx and txnip complex | x-ray diffraction | B, D | — | — |
| 4LL4 | The structure of the TRX and TXNIP complex | x-ray diffraction | B, D | — | — |
| 4LL4 | The structure of the trx and txnip complex | x-ray diffraction | B, D | — | — |
| 4OO4 | Crystal Structure of Human Thioredoxin Mutant | x-ray diffraction | A, B | — | — |
| 4OO4 | Crystal structure of human thioredoxin mutant | x-ray diffraction | A, B | — | — |
| 4OO5 | Crystal Structure of S-nitrosated Human Thioredoxin Mutant | x-ray diffraction | A | — | — |
| 4OO5 | Crystal structure of S-nitrosated human thioredoxin mutant | x-ray diffraction | A | — | — |
| 4POK | Crystal structures of thioredoxin with mesna at 2.5A resolution | x-ray diffraction | A, B, C, D | — | — |
| 4POK | Crystal structures of thioredoxin with mesna at 2.5A resolution | x-ray diffraction | A, B, C, D | — | — |
10 records more on the page itself.
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.